z******n
发帖数: 97 | 1 http://www.forbes.com/sites/matthewherper/2014/01/14/how-merck-
" he says. In hepatitis C, in particular, he notes that molecule are 700 to
1,000 daltons, way bigger than the company would have previously considered
using. But he says he needed to clear out some chemists to hire more
biologists." | A******y
发帖数: 2041 | 2 Merck listened to biologist and brought RNAi technology...listened to
biologist to go after HepC when Gilead is way ahead of it. No one deserved
to be fired but the upper management.
to
considered
【在 z******n 的大作中提到】
: http://www.forbes.com/sites/matthewherper/2014/01/14/how-merck-
: " he says. In hepatitis C, in particular, he notes that molecule are 700 to
: 1,000 daltons, way bigger than the company would have previously considered
: using. But he says he needed to clear out some chemists to hire more
: biologists."
| z******n
发帖数: 97 | 3 This is just a reminder that chilly winter for chemists (organic,
particularly) will be continuing and the trend is not optimistic; on the
other side, for biologists, not sure either.
Not intended to dis-encourage young, enthusiastic folks who are planing or
just entered the industry, but this is the cruel reality. |
|
